Department of Health and Human Services July 18, 2005 – Federal Register Recent Federal Regulation Documents

Fragile X Syndrome Cascade Testing and Genetic Counseling Protocols
Document Number: 05-14049
Type: Notice
Date: 2005-07-18
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Center for Health Statistics, Board of Scientific Counselors
Document Number: 05-14048
Type: Notice
Date: 2005-07-18
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of Issuance of Final Policy Directive
Document Number: 05-14025
Type: Notice
Date: 2005-07-18
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
The Administration for Native Americans (ANA) herein issues final interpretive rules, general statement of policy, and rules of agency procedure or practice in relation to the Social and Economic Development Strategies (SEDS) project SMART NA Communities (Strengthening Marriages and Relationships in Tribal and Native American Communities). For FY 2005, ANA reserved an amount of funding under the SEDS program to fund projects that are beneficial to the development of healthy Native American communities. ANA has decided to participate in ACF's Healthy Marriage Initiative, and intends to use the reserved SEDS funds to support projects that improve child well- being by removing barriers associated with forming and retaining healthy families and marriages in Native American communities. Under the statute, ANA is required to provide members of the public an opportunity to comment on proposed changes in interpretive rules, statements of general policy, and rules of agency procedure or practice, and to give notice of the final adoption of such changes at least 30 days before the changes become effective. The notice also provides additional information about ANA's plan for administering the programs.
Certain Other Dosage Form New Animal Drugs; Oxytetracycline
Document Number: 05-14017
Type: Rule
Date: 2005-07-18
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for use of oxytetracycline hydrochloride soluble powder for skeletal marking of finfish fry and fingerlings by immersion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.